Previous 10 | Next 10 |
Rodrigo Paiva/Getty Images News Some Asian countries that relied on the COVID-19 vaccine from Sinovac Biotech ([[SVA]]) are considering the administration of booster shots amid concerns over its efficacy as the prevalence of coronavirus Delta variant rises across the globe. After vaccinating ...
mphillips007/iStock via Getty Images COVAX has called for all government authorities to recognize as "fully vaccinated" all people who have received COVID-19 vaccines authorized by the World Health Organization ((WHO)) as the Western countries open up their borders to inoculated travellers. T...
JP Yim/Getty Images Entertainment The Director-General of the World Health Organization ((WHO)), Dr. Tedros Adhanom Ghebreyesus on Thursday called for a global effort to vaccinate at least 10% of the population of every country by September against COVID-19. In a virtual address to India Glob...
Sinovac Biotech (SVA) announces The Lancet Infectious Diseases published results from the Phase I/II clinical trials of an inactivated COVID-19 vaccine, CoronaVac, in healthy children and adolescents aged 3-17 in China. The study evaluated the safety, tolerability and immunogenicity of Corona...
- CoronaVac® is safe among the pediatric group aged 3 to 17 years old - CoronaVac can induce strong antibody responses in this pediatric group Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading prov...
Kevin Frayer/Getty Images News Two Chinese COVID-19 vaccines, including ones made by Sinovac Biotech (SVA) and Sinopharm (SHTDF), are less effective in creating antibodies against the Delta variant compared to other strains, Reuters reports. Feng Zijian, former deputy director of the Chi...
China the first country to be hit by the pandemic has completed the administration of 1 billion COVID-19 vaccine doses in the country.As of Saturday, 1,010,489,000 doses have been given to people in the country, CNBC reported citing the data from the National Health Commission ((NHC...
Messenger RNA-based technology that is highly effective in preventing Covid-19 can also be used for treatment of other diseases. High efficacy rates in preventing Covid-19 spark rush by Chinese companies into mRNA vaccines and treatments. At least one Chinese-made mRNA Covid vacci...
SINOVAC Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that CoronaVac®, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences Co., Ltd. (...
The World Health Organization ((WHO)) has granted an emergency use listing for the COVID-19 vaccine developed by Sinovac Biotech (SVA) making it the second Chinese coronavirus vaccine to win the WHO nod.The decision was supported by data indicating that the “inactivatedȁ...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerativ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The annual r...
--News Direct-- Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 –...